DNA repair dysfunction in gastrointestinal tract cancers

Cancer Science

Volumn 99, Issue 3, 2008, Pages 451-458

  Maehara, Yoshihiko ^a   Egashira, Akinori ^a   Oki, Eiji ^a   Kakeji, Yoshihiro ^a   Tsuzuki, Teruhisa ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA GLYCOSYLASE MUTY; DNA GLYCOSYLTRANSFERASE; GENE PRODUCT; MISMATCH REPAIR PROTEIN PMS1; MISMATCH REPAIR PROTEIN PMS2; NUCLEIC ACID BINDING PROTEIN; PROTEIN MLH1; PROTEIN MLH3; PROTEIN MSH2; PROTEIN MSH3; PROTEIN MSH6; PROTEIN OGG1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

CANCER SUSCEPTIBILITY; CARCINOGENESIS; COLON CANCER; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DISORDERS OF DNA SYNTHESIS AND REPAIR; DNA METHYLATION; DNA REPAIR; ENVIRONMENTAL FACTOR; ESOPHAGUS CANCER; GENE DELETION; GENE DISRUPTION; GENE FREQUENCY; GENE INACTIVATION; GENE INSERTION; GENE MUTATION; GENE TARGETING; GENETIC POLYMORPHISM; HEREDITY; HUMAN; MISMATCH REPAIR; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STOMACH CANCER;

EID: 38949121593     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00671.x     Document Type: Review

References (82)

1. Fishel R, Lescoe MK, Rao MR et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. (Published erratum appears in Cell 1994; 77: 167.) Cell 1993; 75: 1027-38.
2. Leach FS, Nicolaides NC, Papadopoulos N et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993; 75: 1215-25.
3. Al-Tassan N, Chmiel NH, Maynard J et al. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet 2002; 30: 227-32.
4. Jiricny J. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 2006; 7: 335-46.
5. Russo MT, Blasi MF, Chiera F et al. The oxidized deoxynucleoside triphosphate pool is a significant contributor to genetic instability in mismatch repair-deficient cells. Mol Cell Biol 2004; 24: 465-74.
6. Buermeyer AB, Deschenes SM, Baker SM, Liskay RM. Mammalian DNA mismatch repair. Annu Rev Genet 1999; 33: 533-64.
7. Liu B, Parsons R, Papadopoulos N et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996; 2: 169-74.
8. Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 2003; 21: 1174-9.
9. Andrew SE, Xu XS, Baross-Francis A et al. Mutagenesis in PMS2- and MSH2-deficient mice indicates differential protection from transversions and frameshifts. Carcinogenesis 2000; 21: 1291-5.
10. Egashira A, Yamauchi K, Yoshiyama K et al. Mutational specificity of mice defective in the MTH1 and/or the MSH2 genes. DNA Repair (Amst) 2002; 1: 881-93.
11. Hegan DC, Narayanan L, Jirik FR, Edelmann W, Liskay RM, Glazer PM. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6. Carcinogenesis 2006; 27: 2402-8.
12. Loeb LA. A mutator phenotype in cancer. Cancer Res 2001; 61: 3230-9.
13. Maehara Y, Oda S, Sugimachi K. The instability within: Problems in current analyses of microsatellite instability. Mutat Res 2001; 461: 249-63.
14. de Wind N, Dekker M, Berns A, Radman M, te Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 1995; 82: 321-30.
15. Reitmair AH, Schmits R, Ewel A et al. MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet 1995; 11: 64-70.
16. Reitmair AH, Redston M, Cai JC et al. Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice. Cancer Res 1996; 56: 3842-9.
17. Chen PC, Dudley S, Hagen W et al. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse. Cancer Res 2005; 65: 8662-70.
18. Edelmann W, Cohen PE, Kane M et al. Meiotic pachytene arrest in MLH1-deficient mice. Cell 1996; 85: 1125-34.
19. Edelmann W, Yang K, Umar A et al. Mutation in the mismatch repair gene Msh6 causes cancer susceptibility. Cell 1997; 91: 467-77.
20. Prolla TA, Baker SM, Harris AC et al. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat Genet 1998; 18: 276-9.
21. Edelmann W, Umar A, Yang K et al. The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression. Cancer Res 2000; 60: 803-7.
22. Edelmann W, Yang K, Kuraguchi M et al. Tumorigenesis in Mlh1 and Mlh1/ Apc1638N mutant mice. Cancer Res 1999; 59: 1301-7.
23. Sands AT, Suraokar MB, Sanchez A, Marth JE, Donehower LA, Bradley A. p53 deficiency does not affect the accumulation of point mutations in a transgene target. Proc Natl Acad Sci USA 1995; 92: 8517-21.
24. Oda S, Zhao Y, Maehara Y. Microsatellite instability in gastrointestinal tract cancers: A brief update. Surg Today 2005; 35: 1005-15.
25. Ikeda Y, Oda S, Abe T, Ohno S, Maehara Y, Sugimachi K. Features of microsatellite instability in colorectal cancer: Comparison between colon and rectum. Oncology 2001; 61: 168-74.
26. Araki K, Wang B, Miyashita K et al. Frequent loss of heterozygosity but rare microsatellite instability in oesophageal cancer in Japanese and Chinese patients. Oncology 2004; 67: 151-8.
27. Oda S, Maehara Y, Ikeda Y et al. Two modes of microsatellite instability in human cancer: Differential connection of defective DNA mismatch repair to dinucleotide repeat instability. Nucleic Acids Res 2005; 33: 1628-36.
28. Lowsky R, Magliocco A, Ichinohasama R et al. MSH2-deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability. Blood 2000; 95: 1767-72.
29. Papadopoulos N, Nicolaides NC, Wei YF et al. Mutation of a mutL homolog in hereditary colon cancer. Science 1994; 263: 1625-9.
30. Liu T, Yan H, Kuismanen S et al. The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res 2001; 61: 7798-802.
31. Uchida N, Kumimoto H, Nishizawa K et al. Mismatch repair and microsatellite instability in esophageal cancer cells. Int J Cancer 2001; 91: 687-91.
32. Guo M, Ren J, House MG, Qi Y, Brock MV, Herman JG. Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus. Clin Cancer Res 2006; 12: 4515-22.
33. Uehara H, Miyamoto M, Kato K et al. Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma. J Surg Oncol 2005; 92: 109-15.
34. Aarnio M, Sankila R, Pukkala E et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999; 81: 214-8.
35. Goecke T, Schulmann K, Engel C et al. Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: A report by the German HNPCC Consortium. J Clin Oncol 2006; 24: 4285-92.
36. Leung SY, Yuen ST, Chung LP, Chu KM, Chan AS, Ho JC. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 1999; 59: 159-64.
37. Fleisher AS, Esteller M, Wang S et al. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 1999; 59: 1090-5.
38. Baek MJ, Kang H, Kim SE et al. Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability. Br J Cancer 2001; 85: 1147-52.
39. Kitajima Y, Miyazaki K, Matsukura S, Tanaka M, Sekiguchi M. Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer. Gastric Cancer 2003; 6: 86-95.
40. Chiaravalli AM, Furlan D, Facco C et al. Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences. Virchows Arch 2001; 438: 39-48.
41. Aaltonen LA, Salovaara R, Kristo P et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998; 338: 1481-7.
42. Percesepe A, Borghi F, Menigatti M et al. Molecular screening for hereditary nonpolyposis colorectal cancer: A prospective, population-based study. J Clin Oncol 2001; 19: 3944-50.
43. Konishi M, Kikuchi-Yanoshita R, Tanaka K et al. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 1996; 111: 307-17.
44. Bubb VJ, Curtis LJ, Cunningham C et al. Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer. Oncogene 1996; 12: 2641-9.
45. Chaves P, Cruz C, Lage P et al. Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype. J Pathol 2000; 191: 355-60.
46. Cunningham JM, Christensen ER, Tester DJ et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 1998; 58: 3455-60.
47. Parc YR, Halling KC, Wang L et al. HMSH6 alterations in patients with microsatellite instability-low colorectal cancer. Cancer Res 2000; 60: 2225-31.
48. Plaschke J, Kruger S, Pistorius S, Theissig F, Saeger HD, Schackert HK. Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation. Int J Cancer 2002; 97: 643-8.
49. Jass JR, Whitehall VL, Young J, Leggett BA. Emerging concepts in colorectal neoplasia. Gastroenterology 2002; 123: 862-76.
50. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; 90: 7915-22.
51. Tajiri T, Maki H, Sekiguchi M. Functional cooperation of MutT, MutM and MutY proteins in preventing mutations caused by spontaneous oxidation of guanine nucleotide in Escherichia coli. Mutat Res 1995; 336: 257-67.
52. Tsuzuki T, Nakatsu Y, Nakabeppu Y. Significance of error-avoiding mechanisms for oxidative DNA damage in carcinogenesis. Cancer Sci 2007; 98: 465-70.
53. Fujikawa K, Kamiya H, Yakushiji H, Nakabeppu Y, Kasai H. Human MTH1 protein hydrolyzes the oxidized ribonucleotide, 2-hydroxy-ATP. Nucleic Acids Res 2001; 29: 449-54.
54. Ohtsubo T, Nishioka K, Imaiso Y et al. Identification of human MutY homolog (hMYH) as a repair enzyme for 2-hydroxyadenine in DNA and detection of multiple forms of hMYH located in nuclei and mitochondria. Nucleic Acids Res 2000; 28: 1355-64.
55. Klungland A, Rosewell I, Hollenbach S et al. Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc Natl Acad Sci USA 1999; 96: 13300-5.
56. Minowa O, Arai T, Hirano M et al. Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proc Natl Acad Sci USA 2000; 97: 4156-61.
57. Sakumi K, Tominaga Y, Furuichi M et al. Ogg1 knockout-associated lung tumorigenesis and its suppression by Mth1 gene disruption. Cancer Res 2003; 63: 902-5.
58. Tsuzuki T, Egashira A, Igarashi H et al. Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase. Proc Natl Acad Sci USA 2001; 98: 11456-61.
59. DeWeese TL, Shipman JM, Larrier NA et al. Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation. Proc Natl Acad Sci USA 1998; 95: 11915-20.
60. Xie Y, Yang H, Cunanan C et al. Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors. Cancer Res 2004; 64: 3096-102.
61. Sakamoto K, Tominaga Y, Yamauchi K et al. MUTYH-null mice are susceptible to spontaneous and oxidative stress induced intestinal tumorigenesis. Cancer Res 2007; 67: 6599-604.
62. Ni TT, Marsischky GT, Kolodner RD. MSH2 and MSH6 are required for removal of adenine misincorporated opposite 8-oxo-guanine in S. cerevisiae. Mol Cell 1999; 4: 439-44.
63. Haracska LYuSL, Johnson RE, Prakash L, Prakash S. Efficient and accurate replication in the presence of 7,8-dihydro-8-oxoguanine by DNA polymerase eta. Nat Genet 2000; 25: 458-61.
64. Maga G, Villani G, Crespan E et al. 8-oxo-guanine bypass by human DNA polymerases in the presence of auxiliary proteins. Nature 2007; 447: 606-8.
65. Sampson JR, Dolwani S, Jones S et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 2003; 362: 39-41.
66. Sieber OM, Lipton L, Crabtree M et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003; 348: 791-9.
67. Croitoru ME, Cleary SP, Di Nicola N et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst 2004; 96: 1631-4.
68. Tenesa A, Campbell H, Barnetson R, Porteous M, Dunlop M, Farrington SM. Association of MUTYH and colorectal cancer. Br J Cancer 2006; 95: 239-42.
69. Halford SE, Rowan AJ, Lipton L et al. Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. Am J Pathol 2003; 162: 1545-8.
70. Kim CJ, Cho YG, Park CH et al. Genetic alterations of the MYH gene in gastric cancer. Oncogene 2004; 23: 6820-2.
71. Shinmura K, Kohno T, Kasai H, Koda K, Sugimura H, Yokota J. Infrequent mutations of the hOGG1 gene, that is involved in the excision of 8-hydroxyguanine in damaged DNA, in human gastric cancer. Jpn J Cancer Res 1998; 89: 825-8.
72. Audebert M, Radicella JP, Dizdaroglu M. Effect of single mutations in the OGG1 gene found in human tumors on the substrate specificity of the Ogg1 protein. Nucl Acids Res 2000; 28: 2672-8.
73. Kim IJ, Ku JL, Kang HC et al. Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients. Hum Genet 2004; 115: 498-503.
74. Kohno T, Shinmura K, Tosaka M et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998; 16: 3219-25.
75. Xing DY, Tan W, Song N, Lin DX. Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer 2001; 95: 140-3.
76. Takezaki T, Gao CM, Wu JZ et al. hOGG1 Ser (326) Cys polymorphism and modification by environmental factors of stomach cancer risk in Chinese. Int J Cancer 2002; 99: 624-7.
77. Kim JI, Park YJ, Kim KH et al. hOGG1 Ser326Cys polymorphism modifies the significance of the environmental risk factor for colon cancer. World J Gastroenterol 2003; 9: 956-60.
78. Kimura Y, Oda S, Egashira A et al. A variant form of hMTH1, a human homologue of the E. coli mutT gene, correlates with somatic mutation in the p53 tumour suppressor gene in gastric cancer patients. J Med Genet 2004; 41: E57.
79. Schafmayer C, Buch S, Egberts JH et al. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer. Int J Cancer 2007; 121: 555-8.
80. Morita M, Kuwano H, Ohno S et al. Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: reference to smoking, drinking and family history. Int J Cancer 1994; 58: 207-10.
81. Ribic CM, Sargent DJ, Moore MJ et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003; 349: 247-57.
82. Hirano S, Tominaga Y, Ichinoe A et al. Mutator phenotype of MUTYH-null mouse embryonic stem cells. J Biol Chem 2003; 278: 38121-4.